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We showed previously that cAMP is a survival-promoting stimulus for cultured postnatal rat spiral ganglion neurons (SGNs) and that
depolarization promotes SGN survival in part via recruitment of cAMP signaling. We here investigate the subcellular locus of cAMP
prosurvival signaling. Transfection of GPKI, a green fluorescent protein (GFP)-tagged cAMP-dependent protein kinase (PKA) inhibitor,
inhibits the ability of the permeant cAMP analog cpt-cAMP [8-(4-chlorophenylthio)-cAMP] to promote survival, indicating that PKA
activity is necessary. Transfection of GFP-tagged PKA (GPKA) is sufficient to promote SGN survival, but restriction of GPKA to the
nucleus by addition of a nuclear localization signal (GPKAnls) almost completely abrogates its prosurvival effect. In contrast, GPKA
targeted to the extranuclear cytoplasm by addition of a nuclear export signal (GPKAnes) promotes SGN survival as effectively as does
GPKA. Moreover, GPKI targeted to the nucleus lacks inhibitory effect on SGN survival attributable to cpt-cAMP or depolarization. These
data indicate an extranuclear target of PKA for promotion of neuronal survival. Consistent with this, we find that dominant-inhibitory
CREB mutants inhibit the prosurvival effect of depolarization but not that of cpt-cAMP. SGN survival is compromised by overexpression
of the proapoptotic regulator Bad, previously shown to be phosphorylated in the cytoplasm by PKA. This Bad-induced apoptosis is
prevented by cpt-cAMP or by cotransfection of GPKA or of GPKAnes but not of GPKAnls. Thus, cAMP prevents SGN death through a
cytoplasmic as opposed to nuclear action, and inactivation of Bad proapoptotic function is a mechanism by which PKA can prevent
neuronal death.
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Introduction
In neurons, the second messenger cAMP mediates prosurvival
signaling, evidenced by the ability of permeant cAMP analogs,
e.g., cpt-cAMP [8-(4-chlorophenylthio)-cAMP], to maintain
neuronal survival in the absence of other trophic factors (Ry-
del and Greene, 1988; Michel and Agid, 1996; Hanson et al.,
1998; Nakao, 1998). In particular, we showed that neonatal rat
spiral ganglion neuron (SGN) survival is promoted in vitro by
cpt-cAMP and by membrane depolarization, with the latter
being more effective (Hansen et al., 2001). This complements
other studies showing that direct electrical stimulation in vivo
reduces the death of SGNs that would otherwise occur after
the loss of hair cells (Leake et al., 1999; Miller, 2001). Ca 2
influx consequent to membrane depolarization leads to in-
creased intracellular cAMP (Kalix and Roch, 1976; Iuvone et
al., 1991; Nakao, 1998; Shen et al., 1999), and promotion of the
survival of SGNs (Hansen et al., 2001) and CNS neurons
(Meyer-Franke et al., 1995; Hanson et al., 1998) in vitro by
membrane depolarization is reduced by a cAMP antagonist.
Thus, cAMP is a prosurvival signal and mediates part of the
prosurvival effect of depolarization.
The cAMP-dependent protein kinase (PKA) is an effector of
cAMP signaling, and we show here that PKA is the major effector
of cAMP prosurvival signaling. After elevation of intracellular
cAMP concentration, the inactive PKA complex dissociates, re-
leasing catalytic subunits, which then phosphorylate substrate
proteins (Francis and Corbin, 1994). Although initially released
in the cytoplasm, catalytic subunits translocate to the nucleus and
so can phosphorylate and regulate transcription factors in addi-
tion to cytoplasmic effectors (Bacskai et al., 1993). An important
nuclear target of PKA is the Ca 2– cAMP-responsive element
binding protein (CREB) family of transcription factors (De Ce-
sare and Sassone-Corsi, 2000). CREB, in particular, is phosphor-
ylated on serine-133 (Ser133), which allows it to recruit the co-
activator CREB binding protein (CBP) and activate
transcription. CREB is a mediator of the prosurvival effect of
neurotrophins in sympathetic and cerebellar granule neurons
(Bonni et al., 1999; Riccio et al., 1999) and plays a critical role in
transcriptional activation of prosurvival genes such as BDNF
(Shieh et al., 1998; Tao et al., 1998) and Bcl-2 (Wilson et al., 1996;
Riccio et al., 1999). PKA can also exert a prosurvival effect by
phosphorylating cytoplasmic targets such as the proapoptotic
regulator Bad, a BH3 domain-only Bcl-2 family member (Harada
et al., 1999; Lizcano et al., 2000; Virdee et al., 2000). PKA is one of
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several protein kinases capable of functionally inactivating Bad
and thus inhibiting apoptosis (Datta et al., 1997; del Peso et al.,
1997; Bonni et al., 1999).
Because PKA can act both in the nucleus and in the cytoplasm,
PKA could contribute to neuronal survival through regulation of
transcription, e.g., activation of CREB-dependent transcription,
or by posttranslational modification of apoptotic regulators, e.g.,
inhibition of the proapoptotic Bad protein. To determine the
relative contribution of nuclear and cytoplasmic PKA function,
we used green fluorescent protein (GFP)-tagged PKA catalytic
subunits (GPKA) and GFP-tagged PKA inhibitor protein (GPKI)
that were restricted to the nucleus or cytoplasm, respectively, by
insertion of a nuclear localization signal (nls) or nuclear export
signal (nes). [In the case of PKI, the nes is endogenous but was
removed in adding the nls (Wen et al., 1994).] Expression of these
constructs in transfected spiral ganglion neurons in vitro shows
that cytoplasmic activity of PKA is necessary and sufficient for its
prosurvival effect but that nuclear activity is dispensable. Consis-
tent with this, we observed that, although CREB is phosphory-
lated by cAMP signaling in SGNs, CREB activity is not necessary
for the prosurvival effect of cAMP. Conversely, cAMP signaling
effectively inactivates the proapoptotic function of Bad, indicat-
ing a prosurvival role for PKA in posttranslational control of
cytoplasmic apoptotic regulators.
Materials and Methods
Spiral ganglion neuron culture and transfection. Our basic culture medium
consisted of high-glucose (4.5 mg/ml) DMEM, 0.1 mg/ml penicillin, 0.1
mg/ml streptomycin, N2 supplement, and 10 g/ml insulin and is des-
ignated here as “5K” because in this medium, [K]  5.4 mM. We also
used a depolarizing medium in which Nawas replaced with equimolar
K to raise [K] to 25 or 30 mM while maintaining osmolarity. These
media are designated here as “25K” or “30K,” respectively. (Survival is
equivalent in either medium.) Before and during transfection, the cul-
tures were maintained in 25K to which 5% fetal bovine serum was added
(“25KS”). The DMEM, antibiotics, and serum were obtained from the
University of Iowa Diabetes and Endocrinology Research Core, and the
other supplements were from Sigma (St. Louis, MO) or Invitrogen
(Carlsbad, CA).
Dissociated cultures of SGNs were prepared from postnatal day 4 –5
rats and maintained by a modification of the methods described previ-
ously (Hegarty et al., 1997). Briefly, rat cochleae were removed from the
temporal bone and placed in ice-cold PBS. Each spiral ganglion was
isolated from the cochlea by sequential removal of the bony cochlear
capsule, the spiral ligament, and the organ of Corti, leaving the spiral
ganglion within the modiolus. These were collected in HBSS on ice and
then transferred to Ca 2–Mg 2-free HBSS with 0.1% trypsin and 0.1%
collagenase at 37°C for 20 min to enzymatically dissociate the cells. After
three washes with culture medium, an additional mechanical dissocia-
tion was performed by trituration using either fire-polished glass Pasteur
pipettes or a mechanical pipettor with 1 ml pipette tips. The dissociated
cells were plated in 25KS. Neurons were plated in tissue culture dishes
(Falcon or Corning, purchased from Fisher Scientific, Houston, TX) or
slides (Lab-Tek, Rochester, NY) previously coated sequentially with
polyornithine (Sigma) (0.1 mg/ml in 10 mM borate buffer, pH 8.4) for 1
hr at room temperature, followed by laminin (Invitrogen) (20 g/ml in
HBSS) overnight at 4°C. Typically, the cells were plated in 48-well culture
plates at a density of approximately one ganglion per well. Thus, there are
5000 neurons per well (28% plating efficiency), and these are10%
of the total number of cells. The low plating efficiency for SGNs is pre-
sumably a result of the extensive dissection and treatment required to
separate the ganglion from the bone.
Transfection was performed when the neurons had firmly attached to
the substrate, 6 hr after plating. We used a calcium phosphate-based
protocol modified from that by Gabellini et al. (1992) as we described
previously (Zha et al., 2001). Briefly, plasmids (see below for description
of plasmids used) were mixed with 1.25 M CaCl2 solution, and then sterile
deionized water was added to bring the CaCl2 concentration to 0.25 M.
An equal volume of 2 depolarizing HEPES buffer (in mM: 50 HEPES,
220 NaCl, 1.5 Na2HPO4, and 60 KCl, pH 7.1) was added slowly and with
agitation. The DNA–Ca 2–PO4 mixture was left for 20 min at room
temperature to allow precipitates to form and then added to the culture
medium (25KS) on the cells at a 1:10 (v/v) ratio, the final concentration
of DNA being 9.1g/ml. After 6 hr, the culture medium containing DNA
mixture was washed once with DMEM and replaced with 25K medium.
We found that the presence of serum before and during the transfection
improves the viability of the neurons but that removal of the serum after
the incubation with DNA–Ca 2–PO4 improves the transfection effi-
ciency. Typically, 5–10% of the SGNs were transfected. In some cases,
multiple plasmids were cotransfected. In experiments performed using
two plasmids that both encode a detectable product, we found that
95% of the transfected cells expressed both gene products.
Immunocytochemistry. After culture for the times indicated, the cells
were fixed for 15 min with 4% paraformaldehyde in PBS, washed with
PBS, and incubated with blocking buffer (PBS, 2% BSA, 5% normal goat
serum, and 0.1% NaN3) for 1 hr at 37°C, then with primary antibodies in
blocking buffer for 1 hr at 37°C or overnight at 4°C, and then with
fluorescently labeled secondary antibodies in blocking buffer for 1 hr at
37°C. After washing with PBS, the nuclei were stained with Hoechst
33342 (10g/ml in PBS) for 15 min, washed again with PBS, and viewed
with a Leica Leitz DMR microscope equipped for fluorescence optics
(Leica, Nussloch, Germany). The images were captured using a Photo-
metrics CH250 cooled CCD camera with IPLab Spectrum software (Sig-
nal Analytics, Vienna, VA). The images were prepared for publication
using Adobe Photoshop and Illustrator (Adobe Systems, San Jose, CA).
NIH Image on a Macintosh computer or the equivalent Image J software
on a Windows computer were used to quantify phospho-CREB immu-
nofluorescence. In the program, a circle was drawn just inside the bound-
ary of each neuronal nucleus, and the intensity of the phospho-CREB
immunofluorescence was determined as the average pixel density within
the circle. Background fluorescence was determined as the average pixel
density within a circle of equal diameter just outside of the nucleus, and
this background was subtracted from the value obtained for nuclear
fluorescence. The scale used was arbitrary but linear and consistent
among all experiments.
The primary antibodies used in this study were rabbit anti-phospho-
CREB antibody, which specifically detects CREB phosphorylated at Ser133
(Upstate Biotechnology, Waltham, MA) (1:1000 dilution) and mouse anti-
neurofilament 200 kDa isoform (NF200) antibody (Sigma) (1:400 dilution)
to identify neurons. Secondary antibodies used were Alexa Fluor 488 goat
anti-rabbit IgG and Alexa Fluor 350 or 568 goat anti-mouse IgG antibodies
(Molecular Probes, Eugene, OR) (1:400 dilution).
Assay of neuronal survival–apoptosis. For survival assays, replicate wells
were prepared for each plasmid or combination of plasmids transfected.
Two wells were fixed 18 hr after the start of transfection, by which time
expression of the introduced genes was already apparent, and were used to
establish the transfection efficiency of that combination of plasmids. The
remaining wells (in separate multiwell plates) were washed three times with
PBS and then maintained for 48 hr under the indicated experimental condi-
tions: 5K medium, 25K medium, or 5K plus 1 mM cpt-cAMP (Calbiochem,
La Jolla, CA). The cells were then fixed, permeabilized, and stained with
anti-NF200 antibody, as described above. All transfected (GFP-expressing)
neuron (NF200-positive) cells in each well were counted to assess survival.
This number was corrected for differing transfection efficiencies among dif-
ferent combinations of plasmids. As noted above, a significant number of
neurons die rapidly within the first 24 hr after plating (our unpublished
observations) (Kim et al., 2001). This is presumably because of the trauma of
removing the ganglion from the bone, because it occurs regardless of the
conditions in which the cultures are maintained. Therefore, the survival of
SGNs maintained in 25K for 48 hr is actually 25% of those that survive
plating. However, to allow for comparison among experiments, the number
of SGNs transfected with GFP only and maintained in 25K was arbitrarily set
to 100%, to which relative survival in other experimental conditions was
normalized.
For apoptosis assays, SGNs were cotransfected with combinations of
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plasmids, described below, including those encoding wild-type or mu-
tant Bad and those encoding GFP or GFP-tagged PKA constructs. After
recovery from transfection, the cultures were maintained for 48 hr in 5K
plus 1% FBS, fixed, and stained with anti-NF200 antibody and Hoechst
33342. SGN apoptosis was established by the presence of condensed
nuclei and of collapsed cytoskeletal organization (see Fig. 8).
Expression constructs. Enhanced green fluorescent protein-C1 (EGFP-
C1) was purchased from Clontech (Cambridge, UK). Wild-type CREB,
CREBm1, and KCREB expression vectors were kindly provided by Drs.
Marc Montminy (University of California, San Diego, Salk Institute, La
Jolla, CA) (Montminy et al., 1990) and Richard Goodman [Oregon
Health Sciences University (OHSU), Vollum Institute, Portland, OR]
(Walton et al., 1992). The PKI and PKInls expression plasmids were
kindly provided by Dr. Philip Stork (OHSU, Vollum Institute, Portland,
OR) (Billiard et al., 2001). The wild-type BAD expression vector was
kindly provided by Dr. Gabriel Nun˜ez (University of Michigan, Ann
Arbor, MI) (del Peso et al., 1997).
A cAMP-dependent protein kinase (PKA) catalytic subunit expression
vector (RSV-PKA-C) was kindly provided by Dr. Richard Maurer (OHSU,
Portland, OR) (Howard et al., 1991). This was used as a template for PCR
amplification of the PKA-C using the following primers:
5-AAGTCCGGAGGCGGCACCATGGGCAACGCCG-3 (forward) and
5-TTGAGCTCGAGAAAACTCAGTAAACTCCTTGCCACACTTCT-3
(reverse).
After PCR amplification, the PKA catalytic subunit cDNA was sub-
cloned into pEGFP-C1 between BspEI and XhoI, which places the PKA
catalytic subunit at the C-terminus of enhanced GFP. This construct was
called GPKA. GPKAnls was constructed by adding a double-stranded
oligonucleotide encoding the SV40 large T antigen nls (PPKKKRKVPG)
(Kalderon et al., 1984) at the C-terminus of GPKA between HindIII and
BamHI. The oligonucleotides used were as follows: 5-AGCTGGC-
GGCACGCCACCTAAGAAGAAGAGAAAGGTGG3 and 5-GATCC-
CACCTTTCTCTTCTTCTTAGGTGGGCTGCCGCC-3.
To make GPKAnes, a double-stranded oligonucleotide encoding the
MEK (mitogen-activated protein kinase kinase) nes (EALQKKLEELELDE)
(Wu et al., 1992) was added to the C-terminus of the GPKA between HindIII
and BamHI. The oligonucleotides used were as follows: 5-AGCTTTGCA-
GAAGAAGCTGGAGGAGCTGGAGCTGGACGAGGGATC-3 and 5-
GATCCCTCGTCCAGCTCCAGCTCCTCCAGCTTCTTCTGCAA-3.
BadARK, an inactive Bad mutant, was constructed by mutating three
conserved amino acids at the BH3 domain of wild-type Bad: leucine 151
to alanine (A), aspartate 156 to arginine (R), and glutamate 157 to lysine
(K). This was done by PCR-mediated mutagenesis. The primers used
were 5-CCCCAATCTCTGGGCAGCGCAGCGCTACGGCCGTGAG-
GCCCGAAGGATGAGCCGTAAGTTTGAGGG-3 (forward) and 5-
TCTAGCGAATTCACTGGGAGGGGGT-3 (reverse). The italicized
nucleotides indicate the mutated sequences. The mutated PCR product
contained unique restriction sites, PflMI and EcoRI. The wild-type Bad
sequence between PflMI and EcoRI was replaced by the PCR product.
Unlike wild-type Bad, overexpression of BadARK did not induce apopto-
sis in the transfected SGNs (see Results).
Results
Targeting of the PKA catalytic subunits to specific
subcellular locations
Addition of permeant cAMP analogs, such as cpt-cAMP, to
cultured neurons, including SGNs, is sufficient to promote
their survival in the absence of other trophic support (Rydel
and Greene, 1988; Michel and Agid, 1996; Hanson et al., 1998;
Nakao, 1998; Hansen et al., 2001). This implies that PKA, a
major downstream effector of cAMP, exerts a prosurvival ef-
Figure 1. Expression of subcellularly targeted GFP-tagged PKA catalytic subunit in SGNs.
SGNs were transfected with GFP, GPKA, GPKAnes, a GFP-tagged PKA to which a nuclear export
signal was added, or GPKAnls, a GFP-tagged PKA to which a nuclear localization signal was
added, as indicated. After fixation, neurons were incubated with anti-NF200 antibody, followed
by Alexa Fluor 568-conjugated secondary antibody. The nuclei were labeled by staining with
Hoechst 33342. The cultures were photographed sequentially with a red filter to detect NF200
immunofluorescence, a blue filter to detect Hoechst 33342 fluorescence, and a green filter to
detect GFP fluorescence. The diagrams above each pair of images show the general structure of
the construct transfected. The left panel of each pair shows a composite of the NF200 and
nucleus images. The corresponding GFP or GPKA images are shown at right. The arrows identify
the location of neuronal nuclei and indicate identical positions in both panels of each pair. Green
fluorescence is evident in the nucleus and cytoplasm of neurons transfected with GFP or GPKA
4
but is evident primarily in the cytoplasm of the GPKAnes-transfected neuron and primarily in
the nucleus of the GPKAnls-transfected neuron. The arrowheads indicate the position of two
non-neuronal cells fortuitously transfected with GPKAnes, showing primarily cytoplasmic local-
ization of GPKAnes in this glial cell and in the neuron.
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fect. To test this hypothesis, we transfected SGNs with a con-
struct encoding GPKA, causing overexpression of PKA activ-
ity in the neurons and identifying the transfected cells with
GFP fluorescence. Because PKA exerts distinct actions in both
the nucleus and the cytoplasm, we distinguished between
them by targeting GPKA to the nucleus or cytoplasm exclu-
sively. To target GPKA to the cytoplasm, we added an MEK nes
to the C-terminus of GPKA (GPKAnes). To target GPKA to
the nucleus, we added a SV40 nuclear localization signal to the
C-terminus of GPKA (GPKAnls). The construction of these
cDNAs is described in Materials and Methods.
The presence of GFP in the encoded proteins allowed verifi-
cation of both their expression in transfected cells and their de-
sired subcellular localization, as shown in Figure 1. Hoechst was
used to mark the nuclei, and anti-NF200 antibody was used to
mark the cytoplasm of the neurons in the culture. As shown in
Figure 1, GPKA, like GFP, was present in both the nucleus and
cytoplasm, coinciding with Hoechst fluorescence and NF200 im-
munofluorescence. In some neurons, GPKA was preferentially
distributed in the cytoplasm rather than in the nucleus (see Fig.
8). In contrast, GPKAnls was present almost exclusively in the
nucleus, primarily coinciding with Hoechst fluorescence,
whereas GPKAnes was present almost exclusively in the cyto-
plasm, not overlapping with Hoechst staining and coinciding
with NF200 immunoreactivity.
Cytoplasmic but not nuclear PKA promotes SGN survival
SGNs were transfected in serum-containing medium, with GFP,
GPKA, or targeted GPKA expression plasmids, and after a recov-
ery period of 18 –20 hr, the serum was washed out and the culture
medium was replaced with one devoid of neurotrophic factors
and containing nondepolarizing 5K. As a control, SGNs were also
maintained in depolarizing culture medium containing 25K, pre-
viously shown to maintain SGN survival. SGN survival was de-
termined 48 hr later by counting only transfected neurons (green
fluorescent and NF200-expressing cells) to determine directly the
consequence of expression of GPKA constructs. GPKA expres-
sion significantly enhanced the survival of SGNs over that of
SGNs expressing only GFP (Fig. 2). This indicates that PKA ac-
tivity is sufficient to promote neuronal survival, implying that
PKA may be responsible for the prosurvival effect of cAMP. We
show below (see Fig. 4) that PKA activity is necessary for the
prosurvival effect of cAMP.
We next determined survival of SGNs expressing subcellularly
targeted GPKAs. Expression of GPKAnes significantly enhanced
SGN survival over that of SGNs expressing GFP (Fig. 2) to an
extent comparable with that of expression of GPKA. This indi-
cates that cytoplasmic PKA activity alone is sufficient for the
survival-promoting effect of PKA. In contrast, transfection of
GPKAnls failed to promote SGN survival; the survival of SGNs
expressing GPKAnls was not significantly different from that of
SGNs expressing GFP alone (Fig. 2). Thus, nuclear PKA activity
does not promote neuronal survival, implying an essential role
for cytoplasmic PKA activity.
In this study of the promotion of survival by cAMP–PKA
signaling, we scored SGN survival after 48 hr in experimental
conditions. This time point was chosen because cAMP–PKA re-
sulted in shrinkage of the SGN somata and neurites, increasing
with time, making it more difficult to identify neurons after 48 hr.
However, because the process of cell death was still continuing at
this time, SGN survival in the control 5K condition was some-
what greater in these experiments than what we observed previ-
ously (Hegarty et al., 1997; Hansen et al., 2001). Also, these ex-
periments all involved transfection, and, as noted in Materials
and Methods, this required maintaining the cultures in serum-
containing medium to improve viability. The inclusion of serum
early in the culture process reduces the rate of SGN death after
subsequent transfer to serum-free conditions, presumably be-
cause we are unable to wash sufficiently vigorously to completely
remove serum components. This further increased SGN survival
in the control 5K condition, reducing the difference between
minimal and maximal survival. However, the differences ob-
tained were significant in all cases, with p 0.001.
Cytoplasmic but not nuclear PKI inhibits the ability of cAMP
and of depolarization to promote survival
We showed previously that the membrane-permeant, specific
cAMP antagonist Rp-cAMPS prevents promotion of SGN sur-
vival by cpt-cAMP and reduces promotion of SGN survival by
depolarization (Hansen et al., 2001). Although use of this reagent
established cAMP as a mediator of the survival-promoting effect
of depolarization, it did not distinguish between cAMP signaling
via PKA and cAMP signaling via other effectors, e.g., Rap1
(Vossler et al., 1997; Grewal et al., 2000). To determine whether
PKA is the principal mediator of the survival-promoting effect of
cAMP and to determine where in the cell PKA activity is required,
we used the PKA inhibitor protein PKI (Walsh et al., 1971). PKI is
an endogenous protein that binds to the PKA catalytic subunit
and inhibits its kinase activity with great specificity and efficacy
(Walsh et al., 1971; Whitehouse and Walsh, 1983). PKI contains
an endogenous nes (Wen et al., 1994), causing it to be generally
excluded from the nucleus. This also allows it to prevent entry of
the PKA catalytic subunit into the nucleus (Wiley et al., 1999),
thus blocking nuclear and cytoplasmic PKA activity (Wiley et al.,
1999; Billiard et al., 2001). In particular, cAMP-dependent
CCAAT/enhancer-binding protein  (C/EBP) translocation to
the nucleus is prevented by cytoplasmic PKI but not by nuclear
PKI, but nuclear PKA does prevent C/EBP-dependent tran-
scription (Billiard et al., 2001).
Figure 2. Expression of cytoplasmic but not nuclear PKA is sufficient to promote SGN sur-
vival. SGNs were transfected with GFP plasmid or with a 1:4 mixture of GFP and GPKA, GPKAnls,
or GPKAnes plasmids and maintained in 5K or 25K culture conditions, as indicated, for 48 hr. The
cultures were then fixed and immunolabeled with anti-NF200 antibody and fluorescent sec-
ondary antibody. Surviving transfected SGNs (i.e., cells that were both GFP-expressing and
NF200-immunoreactive) were counted. To allow combining of results from multiple experi-
ments, SGN survival was normalized to and expressed as a percentage of survival in the 25K
condition, which was arbitrarily assigned a value of 100%. The survival of SGNs maintained in 5K
and transfected with GPKA or GPKAnes was significantly ( p 0.005) different from survival of
SGNs maintained in 5K and transfected with GFP or GPKAnls. Results shown are means of three
or more separate experiments, each performed in duplicate. In this and all figures showing
quantification of survival–apoptosis experiments, the error bars show SD.
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A construct consisting of PKI fused to the C-terminus of GFP
(GPKI) was transfected into SGNs. The GFP tag allowed us to
verify the non-nuclear location of the GPKI (Fig. 3A). Because
PKI prevents both cytoplasmic and nuclear PKA activity, we also
used a modified GPKI, one with the nes replaced with a dual nls
(GPKInls). Nuclear-restricted PKI blocks nuclear but not cyto-
plasmic actions of PKA (Billiard et al., 2001). GPKInls was trans-
fected into SGNs, and its nuclear location was verified by means
of the GFP tag (Fig. 3A). To verify that the expressed PKI con-
structs blocked PKA function in transfected SGNs, we transfected
GPKI or GPKInls into SGNs, exposed the cultures to 1 mM cpt-
cAMP for 30 min to activate PKA, fixed them, and then deter-
mined phospho-CREB immunoreactivity using an anti-
phospho-CREB antibody. Because cells with active PKA
phosphorylate CREB in response to cpt-cAMP, lack of phospho-
CREB immunoreactivity indicates PKA inhibition. We com-
pared phospho-CREB immunoreactivity in adjacent transfected
(GFP-positive) and untransfected SGNs in 10 pairs of SGNs in
GPKI-transfected cultures and 10 pairs of SGNs in GPKInls-
transfected cultures. In all cases, the two PKI constructs blocked
CREB phosphorylation; representative examples are shown in
Figure 3B. These data confirm the efficacy of the PKI constructs.
Moreover, this extends the previous study of C/EBP (Billiard et
al., 2001) to show that CREB activation by cAMP is blocked by
either inhibition of PKA in the nucleus or prevention of PKA
translocation to the nucleus.
After verifying the subcellular localization and function of GPKI
and GPKInls in SGNs, we determined their effect on the survival of
SGNs maintained by cAMP signaling. As shown in Figure 4, GPKI
but not GPKInls inhibited the survival-promoting effect of cpt-
cAMP. This result shows that the prosurvival effect of cAMP signal-
ing is mediated principally by PKA but not by other putative cAMP
effectors, which would not have been inhibited by PKI. Moreover,
because inhibition of any nuclear PKA activity by nuclear-restricted
GPKInls had no effect on survival, PKA activity in the nucleus must
not be necessary for neuronal survival. To verify that the GPKInls
had no effect on cytoplasmic PKA signaling, we cotransfected it with
GPKAnes, and, predictably, there was no significant reduction of
SGN survival (Fig. 4).
We noted previously that cAMP signaling mediates part of the
survival-promoting effect of depolarization (Hansen et al., 2001).
We therefore asked whether this is a consequence of PKA activa-
tion and, if so, whether nuclear or cytoplasmic PKA was required.
As shown in Figure 4, GPKI but not GPKInls partially inhibited
the prosurvival effect of depolarization (i.e., culture in 25K me-
dium). This supports previous studies implicating PKA as a me-
diator of depolarization-promoted survival and indicates that
Figure 3. Expression and function of subcellularly targeted GFP-tagged PKI constructs in
SGNs. SGNs were transfected with GPKI, which contains an intrinsic nuclear export signal, or
with GPKInls, in which the nuclear export signal was deleted and replaced with two nuclear
localization signals, as indicated. A, After allowing 24 hr for expression, the cultures were fixed,
and nuclei and neuronal cytoplasm were labeled with Hoechst 33342 and anti-NF200, respec-
4
tively, as in Figure 1. The diagrams above each pair of images show the general structure of the
construct transfected. The left panel of each pair shows a composite of the nuclei and NF200
images. The corresponding GPKI or GPKInls images are shown at right. The arrows identify the
location of neuronal nuclei and indicate identical positions in both panels of each pair. The
arrowhead indicates the nucleus of a fortuitously transfected glial cell. Green fluorescence is
evident primarily in the cytoplasm of the GPKI-transfected neuron and primarily in the nucleus
of the GPKInls-transfected neuron. B, Cultures transfected with GPKI (top) or GPKInls (bottom),
as in A, were treated for 30 min with 1 mM cpt-cAMP before fixation. Two neighboring SGNs are
shown in each set of panels, one (top) transfected and one (bottom) untransfected. In each set,
left, superimposed blue (NF200) and red (phospho-CREB) images identifying SGNs and showing
phospho-CREB immunoreactivity. Center, Same field using a green filter to detect GFP and
shows the upper neuron of each pair expressing the indicated GFP-tagged PKI construct. Right,
Merged left and center images. For either construct, the transfected neuron exhibits greatly
reduced phospho-CREB immunoreactivity relative to the untransfected.
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nuclear PKA activity, in particular, is not involved. Blockade of
PKA activity throughout the cell inhibits the survival-promoting
effect of cAMP and of depolarization, but blockade only in the
nucleus has no effect. This indicates a cytoplasmic locus of PKA
action in promotion of neuronal survival, consistent with the
results described above showing that overexpression of PKA cat-
alytic subunit in the cytoplasm but not in the nucleus promotes
survival.
CAMP and depolarization induce CREB
phosphorylation in SGNs
Previous studies (Gonzalez and Mont-
miny, 1989) have shown that PKA acti-
vates CREB-dependent transcription by
directly phosphorylating CREB in the nu-
cleus. This phosphorylation is on serine
133 (Gonzalez and Montminy, 1989), so
we used the antibody that specifically rec-
ognizes CREB phosphorylated on serine
133 to determine immunocytochemically
whether CREB is phosphorylated by
cAMP in SGNs. Phospho-CREB immu-
noreactivity was detected with a fluores-
cent secondary antibody. Both depolar-
ization and cpt-cAMP caused increased
CREB phosphorylation (Fig. 5). CREB
phosphorylation caused by cpt-cAMP was
blocked by the cAMP antagonist Rp-
cAMPS, but CREB phosphorylation was
still evident in depolarized neurons incu-
bated with Rp-cAMPS (Fig. 5). Thus, al-
though cAMP-dependent signaling par-
tially accounts for the prosurvival effect of
depolarization, a cAMP-independent
mechanism must also exist to mediate
CREB phosphorylation in response to
depolarization.
Phospho-CREB immunofluorescence
was quantified (using NIH Image) for SGNs transfected with
GPKA constructs or control GFP, allowed 18 hr to express the
proteins, and then maintained for 12 hr in 25K or 5K culture
medium. The immunofluorescence level was determined sepa-
rately for transfected and untransfected neurons in the cultures
and was expressed as a value on a scale that was arbitrary but
consistent among all of the experiments. The data were then plot-
ted in the form of histograms (Fig. 6). Expression of GPKA and
culture in 25K both resulted in a large increase in the percentage
of neurons exhibiting higher levels of phospho-CREB immuno-
reactivity. Transfection by itself did not cause an increase in
CREB phosphorylation, because transfection of GFP or of inac-
tive kinases resulted in no change in phospho-CREB immunore-
activity (data not shown). Thus, depolarization and cAMP sig-
naling both cause a significant increase in CREB phosphorylation
in SGNs.
CREB mediates part of the prosurvival effect of depolarization
but is dispensable for the prosurvival effect of cAMP
It has been shown previously (Bonni et al., 1999; Riccio et al.,
1999) that CREB is required for promotion of neuronal sur-
vival by peptide neurotrophic factors. Because we found that
both depolarization and cAMP caused increased CREB phos-
phorylation in SGNs, we asked whether CREB is also required
for all or part of the prosurvival effect of these stimuli. To test
for a requirement for CREB function, we inhibited endoge-
nous CREB by transfecting into the SGN cDNAs encoding one
of two types of dominant-inhibitory CREB mutants, CREBm1
(Struthers et al., 1991) and KCREB (Walton et al., 1992).
These two mutants were chosen because they inhibit CREB
function by different mechanisms. Also, they inhibit the func-
tion of CREB family members other than CREB itself (Walton
Figure 5. CREB phosphorylation on Ser133 in SGNs treated with cpt-cAMP or depolarized. SGNs were cultured in control
medium containing no trophic additions (5K) or exposed for 15 min to 1 mM cpt-cAMP or depolarizing (30K) medium, as indicated.
Additional cultures included Rp-cAMPS, a cAMP antagonist, which was added 30 min before and throughout the 15 min incubation
with cpt-cAMP or 30K. The cultures were fixed, and neurons were identified by NF200 immunoreactivity (red). Nuclei of all cells
were labeled with Hoechst 33342 (blue). Phosphorylation of CREB on Ser133 was detected by immunofluorescence (green fluo-
rescence superimposed on the blue nuclear Hoechst 33342 fluorescence appears cyan). Increased phospho-CREB immunoreactiv-
ity is evident in nuclei in the cpt-cAMP and 30K conditions relative to the 5K condition. The increase in phospho-CREB immunore-
activity caused by cpt-cAMP but not that caused by depolarization was blocked by Rp-cAMPS, indicating that a cAMP-independent
pathway must exist for phosphorylation of CREB by depolarization.
Figure 4. Expression of cytoplasmic but not nuclear GFP-tagged PKA inhibitor protein inhib-
its SGN survival. SGNs were transfected with GFP (open bars) or with a 1:1 mixture of GFP and
GPKI (light gray bars) or GPKInls (dark gray bars) and maintained in 5K, 1 mM cpt-cAMP, or 25K
culture conditions, as indicated, for 48 hr. Also, SGNs were transfected with a 1:1 mixture of
GPKAnes and GFP, GPKI, GPKInls. Surviving transfected SGNs (i.e., cells that were both GFP-
expressing and NF200-immunoreactive) were counted as in Figure 2 and normalized, in each
experiment, to the number of surviving SGNs in the control 25K condition. The ability of cpt-
cAMP, GPKAnes, or 25K to promote SGN survival was significantly ( p0.005) reduced by GPKI.
GPKInls did not significantly affect SGN survival under these conditions: survival was compara-
ble with that of SGNs transfected with GFP only. Results shown are means of three or more
separate experiments, each performed in duplicate.
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et al., 1992; Jean et al., 1998), including factors such as CREM
(cAMP response element modulator) or ATF-1 (activating
transcription factor 1) that can also be regulated by cAMP.
Both mutants blocked expression from a CRE reporter in re-
sponse to cpt-cAMP in PC12 cells (data not shown).
After transfection, the cultures were maintained in nondepo-
larizing (5K) medium, in 5K medium containing cpt-cAMP, or
in 25K medium. After 48 hr, the cultures were fixed, and trans-
fected neurons were counted as before. Inhibition of CREB func-
tion by either CREBm1 or KCREB significantly reduced the pro-
survival effect of 25K (Fig. 7). In contrast, inhibition of CREB
function had little effect on cAMP-promoted survival (Fig. 7).
Thus, although cAMP causes CREB activation, this appears to be
dispensable for the prosurvival effect of cAMP. This is consistent
with the observations described above showing that nuclear PKA
activity fails to promote survival and that blockade of PKA activ-
ity in the nucleus, which prevents it from activating CREB, does
not significantly affect neuronal survival.
Cytoplasmic activity of PKA rescues SGNs from apoptosis
caused by Bad overexpression
The data described above indicate that nuclear actions of PKA are
not necessary for its prosurvival effect. This is consistent with the
observation that CREB family transcription factors are dispens-
able for the prosurvival effect of PKA, although they are impor-
tant nuclear targets of PKA and are implicated in neuronal sur-
vival mediated by other stimuli. The data implicate a cytoplasmic
effector for the prosurvival effect of PKA, and we next sought to
identify at least one candidate. The proapoptotic regulator Bad
has been shown to be phosphorylated by PKA, and this phos-
phorylation can inactivate the proapoptotic function of Bad
(Harada et al., 1999; Lizcano et al., 2000; Virdee et al., 2000).
Although we could show that GPKA or GPKAnes expression or
treatment with cpt-cAMP all caused Bad phosphorylation in
PC12 cells (X.-M. Zha, D. Li, J. Bok, and S. H. Green, unpub-
lished observations), the small number of cells and the presence
of non-neuronal cells and neurons precluded such a biochemical
determination using these spiral ganglion cultures. Nevertheless,
we were able to ask whether PKA could prevent cell death specif-
ically by functionally inactivating Bad. To do this, we maintained
spiral ganglion cultures in 5K medium containing 1% FBS, which
marginally supports SGN survival, delaying their death. Under
these conditions, overexpression of wild-type Bad caused a large
and rapid increase in the number of apoptotic SGNs (Figs. 8, 9),
whereas higher concentrations of FBS (e.g., 5–10%) prevented
SGN death regardless of Bad overexpression and lower FBS con-
centrations resulted in rapid apoptosis in all cells. The use of 1%
FBS allowed us to readily assess the ability of various agents to
suppress the Bad-induced increase in SGN apoptosis and use this
as a measure of their ability to inactivate Bad.
Bad-transfected cells were identified by cotransfecting GFP.
Apoptosis was determined in transfected neurons by staining
with Hoechst 33342 and observing nuclear pyknosis and by stain-
ing with anti-NF200 and observing collapse of the cytoskeleton.
Typical examples are shown in Figure 8. Nuclear and cytoskeletal
condensation was apparent in Bad-transfected SGNs but was un-
common in untransfected cells in the same culture (Fig. 8A).
Figure 6. Quantification of CREB phosphorylation caused by depolarization or PKA transfec-
tion. SGNs were transfected with GFP or GPKA, as indicated, and allowed 18 hr to express the
proteins. After 12 hr incubation in control 5K or depolarizing 25K culture conditions, the cultures
were fixed and stained for nuclei, NF200, and phospho-CREB immunoreactivity as in Figure 5.
The NF200 immunoreactivity and Hoechst 33342 images were used to identify the positions of
neuronal nuclei on the corresponding phospho-CREB image. The intensity of the phospho-CREB
immunoreactivity was determined as the average pixel density within the circle. Background
fluorescence was determined and corrected for background using NIH Image or Image J as
described in Materials and Methods and plotted here as a histogram of the number of neuronal
nuclei displaying each intensity value. The histograms for neurons cultured in depolarizing
medium and for neurons transfected with GPKA show a shift from a condition in which most
SGNs have low levels of phospho-CREB immunoreactivity to one in which all SGNs have varying
but much higher levels of phospho-CREB immunoreactivity.
Figure 7. Expression of dominant-inhibitory CREB mutants inhibits the prosurvival effect of
depolarization but not that of cpt-cAMP. SGNs were transfected with a 1:3 mixture of GFP
plasmid and plasmid encoding either wild-type CREB (open bars), CREBm1 (light gray bars), or
KCREB (dark gray bars); the latter two are dominant-inhibitory CREB mutants. The cultures were
maintained in control (5K), depolarizing (25K), or 1 mM cpt-cAMP culture conditions, as indi-
cated, for 48 hr. Surviving transfected SGNs were counted as in Figure 2 and normalized, in each
experiment, to the number of surviving SGNs in the control 25K condition. Results shown are
means of three separate experiments, each performed in duplicate. The ability of 25K to pro-
mote SGN survival was significantly ( p 0.005) reduced by either CREB mutant but was not
affected by wild-type CREB. In contrast, the survival-promoting effect of cpt-cAMP was unaf-
fected by the CREB mutants.
Bok et al. • Prosurvival cAMP Signaling in Neurons J. Neurosci., February 1, 2003 • 23(3):777–787 • 783
Transfection of GFP alone (data not shown) or of BadARK, an
inactivated Bad mutant, did not cause increased apoptosis (Fig.
8B,C). Increased apoptosis was not observed in SGNs cotrans-
fected with Bad and GPKA or GPKAnes (Fig. 8D,E) but was
observed in SGNs cotransfected with Bad and GPKAnls (Fig. 8F).
These data are quantified in Figure 9. For cultures maintained
in 1% FBS, transfection of wild-type Bad increased the percent-
age of apoptotic SGNs from 30 to 70%. This increase was
entirely a result of overexpression of Bad, because transfection of
an inactivated mutant Bad (BadARK) resulted in no change in the
percentage of apoptotic SGNs. This increase in apoptosis was
almost entirely reversed by cotransfection of GPKA or GPKAnes
but was unaffected by cotransfection of GPKAnls. Thus, cyto-
plasmic PKA but not nuclear PKA activity results in functional
inactivation of Bad, which suggests that Bad inactivation is a
means by which PKA can promote neuronal survival.
Discussion
cAMP promotes survival through cytoplasmic PKA activity
The second messenger cAMP has been shown to be a prosurvival
signal, suggesting that stimuli, e.g., hormones or neurotransmitters,
4
indicate identical positions in each pair of images. The images were chosen so that each shows
a typical transfected and a typical untransfected neuron. Untransfected neurons are indicated
by white arrows. Transfected neurons that are apoptotic (identified by their condensed nuclei
and collapsed cytoplasm) are indicated by red arrows. Transfected nonapoptotic neurons are
indicated by green arrows. Shown in the image pairs from top to bottom: transfection of wild-
type Bad results in apoptosis but BadARK does not. Cotransfection of GPKA or GPKAnes with Bad
results in nonapoptotic cells, but cotransfection of GPKAnls with Bad does not prevent Bad-
induced apoptosis.
Figure 8. Expression of cytoplasmic GPKA rescues SGNs from apoptosis caused by Bad over-
expression. SGNs were transfected with wild-type Bad or inactive mutant Bad plasmids in a 1:1
mixture with GFP-tagged PKA or control GFP plasmids, as indicated. Eighteen hours after trans-
fection, the cultures were switched to culture medium containing 1% horse serum and, 48 hr
later, were fixed and stained as in Figure 2. Transfected cells were identified by green GFP
fluorescence, shown in the right panel of each pair of images. Neurons were identified by NF200
immunoreactivity (red), and nuclei were stained with Hoechst 33342 (blue). These images were
superimposed and are shown in the left panel of each pair. Arrows point to neuronal nuclei and
Figure 9. Quantification of rescue of SGNs by PKA from apoptosis caused by Bad overexpres-
sion. SGNs were transfected with GFP plasmid ( first column) or a 1:1 mixture of GFP with either
Bad or BadARK (second and third columns) or a 1:1 mixture of wild-type Bad with GFP-tagged
PKA constructs ( fourth through sixth columns). Eighteen hours after transfection, the cultures
were switched to culture medium containing 1% horse serum and, 48 hr later, were fixed and
stained as in Figure 8 to distinguish apoptotic and nonapoptotic transfected SGNs. Randomly
selected neurons were scored, and the percentage of apoptotic SGNs in each condition was
calculated. Each column shows the mean and SD of at least three separate determinations, each
performed in duplicate. The total number of SGNs counted is shown above each bar; the number
in parentheses is the number of separate experiments pooled to obtain this number of SGNs.
Expression of Bad but not of BadARK caused a significant ( p0.001) increase in the number of
apoptotic SGNs. This increase, in turn, was prevented by transfection of GPKA or GPKAnes but
not by transfection of GPKAnls: the percentage of apoptotic transfected neurons was signifi-
cantly lower ( p 0.001 and p 0.01, respectively) in cultures transfected with Bad and GPKA
or GPKAnes than in those transfected with Bad and GFP or GPKAnls. There was no significant
difference in the percentage of apoptotic transfected neurons between cultures transfected
with Bad plus GFP and those transfected with Bad plus GPKAnls. There was no significant
difference in the percentage of apoptotic transfected neurons among cultures transfected with
GFP only, BadARK plus GFP, Bad plus GPKA, or Bad plus GPKAnes.
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that raise intracellular cAMP levels could use cAMP to promote
survival. This seems to be the case for at least one critically important
prosurvival stimulus, membrane depolarization: the Ca2 increase
that is the immediate consequence of membrane depolarization can
increase cytosolic cAMP levels via Ca2–calmodulin-dependent ad-
enylyl cyclase (Antoni, 2000). This has been observed in the promo-
tion of motor neuron survival by depolarization (Hanson et al.,
1998). Blockade of cAMP signaling prevents or reduces the ability of
depolarization to promote the survival of retinal ganglion cells
(Meyer-Franke et al., 1995), motor neurons (Hanson et al., 1998),
and SGNs (Hansen et al., 2001), indicating that cAMP signaling is
necessary, at least in part, for depolarization to promote the survival
of CNS and PNS neurons.
CAMP can act via both PKA-dependent and -independent path-
ways, and PKA itself can act in both the cytoplasm and the nucleus.
To distinguish among these alternative pathways by which cAMP
could promote survival, we used a specific PKA inhibitor protein
(PKI) directed to either a nuclear or cytoplasmic location and cata-
lytic PKA subunits likewise directed to either a nuclear or cytoplas-
mic location. The effect of these constructs on SGN survival indicates
that cAMP exerts its survival-promoting effect via PKA and more
specifically via cytoplasmic PKA. This is not consistent with a role for
CREB in cAMP prosurvival signaling, in contrast to the CREB re-
quirement for prosurvival signaling by neurotrophins (Bonni et al.,
1999; Riccio et al., 1999). Indeed, we find that direct blockade of
CREB with dominant-negative mutants did not compromise the
ability of cAMP to promote survival. That PKA acts in the cytoplasm
to promote survival is consistent with previous studies, discussed
below, that have identified means by which cAMP signaling can
promote survival through various actions that seem to take place in
the cytoplasm. One of these is phosphorylation of the BH3 domain-
only Bcl-2 family member Bad by PKA (Harada et al., 1999; Lizcano
et al., 2000; Virdee et al., 2000). Indeed, we found that cytoplasmic
but not nuclear PKA causes Bad phosphorylation in a neuronal cell
line (Zha, Li, Bok, and Green, unpublished observations), and we
show here that cytoplasmic but not nuclear PKA inactivates the pro-
apoptotic effect of Bad in spiral ganglion neurons.
CREB activity is not required for the prosurvival effect
of cAMP
An unexpected result of these studies is that blockade of CREB
activity with dominant-negative mutants did not affect the ability
of cAMP to maintain neuronal survival, indicating that CREB
activity is not required. This is surprising in view of previous
studies showing that CREB is required for the prosurvival effect
of neurotrophins (Bonni et al., 1999; Riccio et al., 1999) and of
our present observation that CREB is required for at least part
of the prosurvival effect of depolarization (Fig. 7). The inability of
these CREB dominant-negative mutants to inhibit the prosur-
vival effect of cAMP is unlikely to be caused by incomplete inhi-
bition of CREB, because the same mutants did inhibit the pro-
survival effect of depolarization in this study and the prosurvival
effect of neurotrophins in other studies (Bonni et al., 1999; Riccio
et al., 1999). The lack of a CREB requirement for the survival-
promoting effect of cAMP is not caused by a lack of CREB acti-
vation by cAMP: cAMP and PKA cause CREB phosphorylation in
SGNs comparable with that caused by depolarization (Figs. 5, 6)
and, in a neuronal cell line, induce transcription from a CRE
reporter comparable with that induced by depolarization or neu-
rotrophins (Bok, Li, and Green, unpublished observations).
In SGNs, the ability of depolarization to activate CREB does not
require cAMP (Fig. 5) and may depend primarily on Ca2/
calmodulin-dependent protein kinase (CaMK) signaling (Hansen et
al., 2003). Both cAMP and CaMKIV phosphorylate CREB, allowing
it to recruit CBP and so promote transcription (Chrivia et al., 1993;
Kwok et al., 1994). However, recruitment of CBP may not be suffi-
cient: although a VP16-CREB fusion protein, which directly acti-
vates transcription, could promote survival of CNS neurons (Bonni
et al., 1999; Riccio et al., 1999) and SGNs (Bok, J. Huang, and Green,
unpublished observations), a mutant that constitutively binds CBP
(Cardinaux et al., 2000) could not promote SGN survival (Bok,
Huang, and Green, unpublished observations). This suggests that
additional posttranslational modification of CBP is necessary for
prosurvival function of CREB-dependent transcription, and this
may distinguish cAMP and CaMKIV signaling.
Both CaMKIV and cAMP signaling potentiate CREB-depend-
ent transcription (Chawla et al., 1998; Cardinaux et al., 2000;
Impey et al., 2002) at the level of CBP or downstream of CBP.
However, although CaMKIV has been shown to directly phos-
phorylate CBP on Ser301 (Impey et al., 2002), the region of CBP
containing this site is entirely dispensable for transcription in-
duction by PKA (Zanger et al., 1999). Moreover, although Xu et
al. (1998) implicated the consensus PKA phosphorylation site in
CBP, Ser1772, in transcriptional activation by PKA, Zanger et al.
(1999) showed transcriptional activation by PKA in CBP mutants
lacking this site. Therefore, depolarization and CaMKIV may dif-
fer from PKA in the mechanism by which they potentiate CREB-
dependent transcription, and this could result in distinct patterns
of CREB-dependent transcription in which CaMKIV-activated
but not PKA-activated genes contribute to survival. Alternatively,
the pattern of CREB-dependent transcription is the same be-
tween CaMKIV and cAMP, but CaMKIV might activate, in ad-
dition to CREB, effectors that allow CREB-dependent transcrip-
tion to contribute to neuronal survival. Thus, CREB would be
necessary in the context of promotion of survival by depolariza-
tion but not in the context of promotion of survival by cAMP.
CREB knock-out compromises the survival of certain periph-
eral neurons (Lonze et al., 2002), e.g., sympathetic neurons, at a
developmental stage at which they are dependent on target-
derived neurotrophic factors. This is consistent with the observed
CREB requirement for support by NGF of cultured neonatal
sympathetic neurons (Riccio et al., 1999). As neurons mature and
lose their dependence on peptide neurotrophic factors, stimuli
such as electrical activity or neurotransmitters that use cAMP
signaling may become more important for maintenance of sur-
vival. We speculate that this also involves a shift away from a
completely CREB-dependent prosurvival mechanism, which
may be essential in allowing a role for CREB in neuronal plasticity
and other functions in mature neurons.
Cytoplasmic effectors of cAMP prosurvival signaling
Protein kinase B (PKB, Akt) is a multifunctional prosurvival sig-
nal (Datta et al., 1999). Because cAMP can activate PKB (Sable et
al., 1997; Filippa et al., 1999), it might represent a possible cyto-
plasmic target of PKA for prosurvival signaling. Another poten-
tial prosurvival signaling pathway, activated in the cytoplasm, is
the MEK–ERK (extracellular signal-regulated kinase) pathway,
and this pathway has been shown to be activated by PKA (Impey
et al., 1998). However, inhibition of PI-3-OH kinase, an up-
stream activator of PKB, or of PKB itself does not significantly
reduce cAMP-promoted survival in sympathetic (Crowder and
Freeman, 1999), cerebellar granule (Miller et al., 1997; Li et al.,
2000), or spiral ganglion neurons (Hansen et al., 2001), and in-
hibition of MEK also does not significantly reduce cAMP-
promoted survival in these diverse types of neurons (Creedon et
al., 1996; Hansen et al., 2001). Thus, cAMP signaling can pro-
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mote survival without recruiting these signal pathways recruited
by peptide neurotrophic factors. This is in contrast to retinal
ganglion neurons in which cAMP has been shown to promote
survival by inducing translocation of a neurotrophin receptor
(TrkB) to the cell membrane, thus enhancing the responsiveness
of the neurons to exogenous BDNF (Meyer-Franke et al., 1998).
Moreover, the ability of cAMP to promote SGN survival is not
affected by using TrkB-IgG or TrkC-IgG fusion proteins to block
neurotrophin binding to neurotrophin receptors on SGNs (Han-
sen et al., 2001). Thus, the mechanism operating in retinal gan-
glion neurons for response to cAMP may be a distinctive feature
of those cells and, possibly, other types of CNS neurons, as has
been suggested (Meyer-Franke et al., 1995, 1998).
The data presented here suggest that cAMP, acting through PKA,
can directly affect the apoptotic regulatory apparatus. Here, we iden-
tified the proapoptotic regulator Bad as a target of cAMP signaling
that allows cAMP, via PKA, to affect the apoptotic decision in neu-
rons. Specifically, we show that PKA can rescue SGNs from apopto-
tic death by functionally inactivating Bad that has been overex-
pressed in the neurons. This is consistent with previous studies
(Harada et al., 1999; Lizcano et al., 2000; Tan et al., 2000; Virdee et al.,
2000; Zhou et al., 2000) that have shown that PKA can phosphory-
late Bad in a manner that potentially interferes with the ability of Bad
to interact with other Bcl-2 family apoptotic regulatory proteins on
the mitochondrion and perform a proapoptotic function. Although
they indicate that PKA can promote survival via Bad inactivation,
these data do not rule out other mechanisms by which PKA can, in
parallel, suppress cell death by targeting cytoplasmic effectors. For
example, glycogen synthase kinase 3 is a proapoptotic effector that
has been shown to be phosphorylated and inactivated by PKA in
cerebellar granule neurons (Li et al., 2000). Moreover, although the
data argue against a nuclear role for PKA in maintaining neuronal
survival, they do not completely exclude transcription-dependent
mechanisms; PKA might regulate transcription while in the cyto-
plasm. One example of this is activation of nuclear factor (NF)-B,
which can act as a prosurvival effector (Foehr et al., 2000; Yang et al.,
2000; Sarmiere and Freeman, 2001). PKA can act in the cytoplasm to
stimulate the DNA-binding ability of NF-B and its translocation
from cytoplasm to nucleus (Shirakawa and Mizel, 1989). Cytoplas-
mic PKA activity is sufficient to cause nuclear translocation of
C/EBP, although nuclear PKA is required for its transcriptional
activity (Billiard et al., 2001). Additional studies, focused on such
cytoplasmic targets of PKA, should define the mechanisms by which
cAMP promotes neuronal survival.
Additivity among survival-promoting factors
Neurons are normally exposed to multiple potential survival-
promoting factors, e.g., peptide neurotrophic factors and stimuli,
such as membrane depolarization, that can raise cAMP levels.
These can cooperate to promote survival, and we showed that this
is indeed the case for spiral ganglion neurons for which cAMP,
depolarization, and neurotrophins promote survival in an addi-
tive manner (Hegarty et al., 1997). Neurotrophins promote sur-
vival, at least in part, via a nuclear mechanism, recruitment of
CREB (Bonni et al., 1999; Riccio et al., 1999), whereas cAMP
apparently promotes survival via cytoplasmic targets. We suggest
that the additivity observed is not a result of their convergence on
a common target but rather of their targeting different points in
the sequence of molecular events that control survival. Neurotro-
phins and CaMKIV control the synthesis of apoptotic regulators,
whereas cAMP posttranslationally controls the activity of apo-
ptotic regulators in the cytoplasm.
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